{
    "code": 0,
    "data": [
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 31St December 2024",
            "news_body": "The board of Director of the company has as its meeting held on Monday 3rd February 2025 inter-alia considered and approved the Un-audited Financial Results of the company for the quarter & nine months ended 31st December 2024 along with Limited Review Report of the Statutory auditors. We are enclosing herewith un-audited financial results along with limited review report.",
            "news_id": "ccf887ca-e33c-4cb6-9a72-2b8be9d7b550",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7b0ab43-7e52-4f81-bcea-dab4fa7dfe5e.pdf",
            "news_date": "2025-02-03 16:51:16",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "RESULTS FOR THE QUATERENDD 30TH SEPTEMBER,2024",
            "news_body": "THE BOARD OF DIRECTOR EETING HELD ON TODAY I.E., 30TH OCTOBER, 2024, HAS CONSIDERED AND APPROVED THE UN-AUDITED FINANCIAL RESULTS FOR HE QUATER ENDED 30TH  SEEPTEMBER, 2024.WE ARE  EN-CLOSING HEREWITH UNAUDITED FINANCIAL RESULTS ALONG WITH LIMITED REVIEW REPORT BY THE AUDITORS.",
            "news_id": "a3bbf484-7f71-4205-82c0-c5912aee2df4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=652eaa04-f83e-48b6-854a-8e7c8d70c8a5.pdf",
            "news_date": "2024-10-30 17:03:36",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2024",
            "news_body": "we are enclosing herewith unaudited financial results for the quarter ended as approved by the board of directors at their meeting held today that is 05-08-2024. the board meeting ended at 5:45pm",
            "news_id": "97c97a37-e757-49e6-a0ee-57b2e525cdc2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94f36614-a4b5-4fd3-bb6c-89709c56a21a.pdf",
            "news_date": "2024-08-05 18:00:10",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March, 2024",
            "news_body": "this is to inform that the Board of directors of the company has, at its meeting held on Friday,17th May,2024 inter-alia:1. approved the audited Financial Statements for the year ended 31st Marc,2024.2 Recommended a dividend @45% i.e, Rs 4.5 per share for te financial year 2023-24Details are given in the annexures.",
            "news_id": "b911d872-201f-44c2-9019-0d8ac4fca05b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fc45c34-86f5-43a2-9f4d-c0954d7fac41.pdf",
            "news_date": "2024-05-17 14:16:02",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March, 2024",
            "news_body": "this is to inform that the Board of directors of the company has, at its meeting held on Friday,17th May,2024 inter-alia:1. approved the audited Financial Statements for the year ended 31st Marc,2024.2 Recommended a dividend @45% i.e, Rs 4.5 per share for te financial year 2023-24Details are given in the annexures.",
            "news_id": "b3ec14ff-5a46-42a0-96f4-412f711d528b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d53e300a-1e91-4e4a-8f33-896da11ddde0.pdf",
            "news_date": "2024-05-17 14:15:24",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter & Nine Months Ended 31St December, 2023.",
            "news_body": "The Board of Directors of the Company has at its meeting held on 6th February, 2024 inter-alia considered and approved the unaudited financial results for the quarter and nine months ended 31st December, 2023.",
            "news_id": "535e61a9-5e6a-4c1f-bdd8-a3e012e30bc0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53c34e2c-d05a-4c7f-83ee-5daa5ed40378.pdf",
            "news_date": "2024-02-06 17:51:03",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30Th June, 2023",
            "news_body": "we are enclosing hereby un-audited financial results for the quarter ended 30th June, 2023 along with a copy of the Limited Review Report by the Statutory Auditor of the Company.",
            "news_id": "a045d81c-b2e3-49dc-aa51-a619ed5a8c1f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fcd7af8-9762-4eae-bf5c-fda9414d90d9.pdf",
            "news_date": "2023-08-04 17:37:08",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 4Th August, 2023",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 4th August, 2023 (i.e. today), inter-alia, considered and approved the following items: <BR> <BR> 1. The Un-audited Financial Results of the company for the quarter ended 30th June, 2023. <BR> 2. Change in Directorship - Resignation by Director<BR> 3. Convening Annual General Meeting  <BR> 4. Fixation of Record/Book Closure Dates<BR> <BR> The Board meeting commenced at 3.00 p.m. and ended at 5:15 p.m.<BR>",
            "news_id": "de1f6c3a-e329-479d-979f-81f96c7369d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=878e1e75-8428-4890-a2c5-9a227cdadb36.pdf",
            "news_date": "2023-08-04 17:30:38",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Half Year Ended 31St March, 2023",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2023.",
            "news_id": "80edb1f1-c5c5-4222-b195-a2392dce8d4a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40f44b06-1a53-4447-9e14-9d610a66cb5c.pdf",
            "news_date": "2023-05-23 17:27:09",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Financial Year Ended 31St March, 2023 And Recommendation Of Dividend",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 23rd May, 2023 (i.e. today), inter-alia : <BR> <BR> 1. Approved the Audited Financial Statements for the year ended 31st March, 2023 and Audited Financial Results for the quarter/year ended 31st March, 2023, as recommended by the Audit Committee; and<BR> 2. Recommended a dividend @ 30% i.e. Rs. 3.00 per share for the financial year 2022-23. <BR>  The meeting of the Board of Directors commenced at 3.00 p.m. and concluded at 5:00 p.m.<BR> <BR> We shall inform you in due course of time, the date on which the Company will hold its Annual General Meeting for the year ended 31st March, 2023, and the date from which dividend, if approved by the shareholders, will be paid or warrants thereof dispatched to the shareholders. <BR>",
            "news_id": "76140a29-d95f-49b2-9606-afa38c802931",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4eba612f-25d1-4fa9-8e85-f4b777177550.pdf",
            "news_date": "2023-05-23 17:18:16",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Nine Months  Ended 31St December, 2022",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 8th February, 2023 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter and nine months  ended 31st December, 2022, along with the Limited Review Report of the statutory auditor. <BR> <BR> We are enclosing herewith the Un-audited Financial Results for the quarter and nine months  ended 31st December, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. <BR> <BR> The Board meeting commenced at 3.00 p.m. and ended at 5.30 p.m.<BR> <BR>",
            "news_id": "3f66e89c-aa9a-46a4-963e-458f900717b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5923073-8127-48d5-85d9-bd51d299c1f5.pdf",
            "news_date": "2023-02-08 17:44:55",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 8Th February, 2023",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 8th February, 2023 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter and nine months  ended 31st December, 2022, along with the Limited Review Report of the statutory auditor. <BR> <BR> We are enclosing herewith the Un-audited Financial Results for the quarter and nine months  ended 31st December, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. <BR> <BR> The Board meeting commenced at 3.00 p.m. and ended at 5.30 p.m.<BR>",
            "news_id": "05d70436-aa2e-4e44-ae57-f25f1bf8a38b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a395f11-2143-4c96-b605-0bff67afad1c.pdf",
            "news_date": "2023-02-08 17:40:39",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 30th September, 2022.",
            "news_id": "193b6ed7-c83a-43c9-bf85-c67d4dddd319",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46d1a0ac-2a0a-45c4-82a6-c65edd7d4139.pdf",
            "news_date": "2022-11-07 15:05:52",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 4th November, 2022 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter & half year  ended 30th September, 2022, along with the Limited Review Report of the statutory auditor. <BR> <BR> We are enclosing herewith the Un-audited Financial Results for the quarter & half year  ended 30th September, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. <BR> <BR> The Board meeting commenced at 3.30 p.m. and ended at 5.25  p.m.<BR> <BR>",
            "news_id": "f8ca637d-76c4-4604-82ea-f37f34bd618e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2c1c749-a257-4dff-afe2-dd7b7b7e6dfb.pdf",
            "news_date": "2022-11-04 17:37:35",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Monday, 8th August, 2022 (i.e. today), inter-alia, considered and approved the following items:  <BR> 1. Considered and approved the Un-audited Financial Results for the quarter ended 30th June, 2022, along with the Limited Review Report of the statutory auditor. <BR> 2. Approved convening the thirty-fourth Annual General Meeting (AGM) of the Company, on Friday, 23rd September, 2022, through video conferencing and other audio visual means.<BR> 3. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 17th September, 2022 to Friday, 23rd September, 2022  (both days inclusive) for the purpose of the AGM and declaration of dividend.<BR> The Board meeting commenced at 3.00 p.m. and ended at 5.20  p.m.<BR>",
            "news_id": "12ea6029-a2f5-4442-a095-6b43a0a1b2fb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d089cf89-9ba0-40bd-bb4b-c201eaa3aaf9.pdf",
            "news_date": "2022-08-08 17:32:36",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2022.This is for your information and record.",
            "news_id": "94621010-4c1e-45c1-b19c-d015bf92b9f7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4436a82-6767-41f9-b844-a28ad7f652f9.pdf",
            "news_date": "2022-05-24 14:50:11",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Audited Financial Results & Dividend",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 20th May, 2022 (i.e. today), inter-alia : <BR> <BR> 1. Approved the Audited Financial Statements for the year ended 31st March, 2022 and Audited Financial Results for the quarter/year ended 31st March, 2022, as recommended by the Audit Committee; <BR> 2. Recommended a dividend @ 25% i.e. Rs. 2.50 per share for the financial year 2021-22.; and <BR> 3. Re-appointed, based on the recommendation of the Audit Committee,  S. N. Dhawan & Co LLP, Chartered Accountants (Firm Reg. No. 000050N/N500045) as the Statutory Auditors of the Company for the second term of 5 years i.e. from the conclusion of the thirty-fourth Annual General Meeting (AGM) of the Company to be held in September, 2022 up to the conclusion of the thirty-ninth AGM of the Company to be held in the year 2027, subject to approval of the shareholders of the Company.  <BR>",
            "news_id": "826a173a-91fa-4834-a0b0-666aa9bf7102",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb82e258-fee8-4342-821d-2a008614bfe9.pdf",
            "news_date": "2022-05-20 18:15:40",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Year Ended 31St March, 2022",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 20th May, 2022 (i.e. today), inter-alia : <BR> <BR> 1. Approved the Audited Financial Statements for the year ended 31st March, 2022 and Audited Financial Results for the quarter/year ended 31st March, 2022, as recommended by the Audit Committee; <BR> 2. Recommended a dividend @ 25% i.e. Rs. 2.50 per share for the financial year 2021-22.; and <BR> 3. Re-appointed, based on the recommendation of the Audit Committee,  S. N. Dhawan & Co LLP, Chartered Accountants (Firm Reg. No. 000050N/N500045) as the Statutory Auditors of the Company for the second term of 5 years i.e. from the conclusion of the thirty-fourth Annual General Meeting (AGM) of the Company to be held in September, 2022 up to the conclusion of the thirty-ninth AGM of the Company to be held in the year 2027, subject to approval of the shareholders of the Company.  <BR>",
            "news_id": "4b5976c9-9559-4f19-b56b-1b3ff58e8149",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=923fca41-73ee-4433-aac2-0607ad609c90.pdf",
            "news_date": "2022-05-20 18:12:09",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December 2021",
            "news_body": "The Board of Directors of the Company, at their meeting held on 8th February, 2022, have approved the Unaudited Financial Results for the quarter and nine months ended 31st December, 2021.<BR> <BR> We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2021, along with a copy of the Limited Review Report by the Auditors.<BR> <BR> The Board meeting started at 3.00 p.m. and ended at 5.55 p.m.",
            "news_id": "c7bb0cac-c846-4018-8946-5017c110c3d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2eef341f-10cb-4dfb-9d0b-d426e37bc08d.pdf",
            "news_date": "2022-02-08 18:09:23",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2021",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 30th September, 2021.<BR> <BR> This is for your information and record.<BR>",
            "news_id": "3f13ef29-fa18-45fd-95ba-367b1be89673",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3308093b-da74-464b-9c7e-bae545d0f755.pdf",
            "news_date": "2021-11-16 11:53:50",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2021",
            "news_body": "The Board of Directors of the Company, at their meeting held on 9th November, 2021, have, inter alia, approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2021.<BR> <BR> We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2021, along with a copy of the Limited Review Report by the Auditors.<BR> <BR> The Board meeting started at 3.00 p.m. and ended at 5.05 p.m.<BR>   <BR> This is for your information and record.<BR>",
            "news_id": "a8823cc3-c6d8-48e3-b34a-e6c1eabc8260",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84e1a554-5a4a-485a-bd81-c7d9036ed139.pdf",
            "news_date": "2021-11-09 17:14:27",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2021",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th August, 2021 (i.e. today), inter-alia, considered and approved the following items: <BR> 1. Considered and approved the Un-audited Financial Results for the quarter ended 30th June, 2021, along with the Limited Review Report of the statutory auditor.<BR> 2. Approved the re-appointment of Mr. P. Shivakumar (DIN : 08570283) as Managing Director, for a period of 3 years effective from 5th November, 2021 to 4th November, 2024, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.<BR> 3. Approved convening the thirty-third Annual General Meeting (AGM) of the Company, on Friday, 24th September, 2021, through video conferencing and other audio visual means.<BR> 4. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 18th September, 2021 to Friday, 24th September, 2021  (both days inclusive) for the purpose of the AGM.",
            "news_id": "88ba6c4e-54fc-45d0-ad8c-3ba84abb8371",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a52bde11-725e-4796-a46a-59f3d24d66f0.pdf",
            "news_date": "2021-08-09 17:44:43",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Trasnactions",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2021.",
            "news_id": "38f565a6-7e4a-4091-a4b8-e184695d1824",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4664f85d-2261-4245-a1bc-da2e212b141d.pdf",
            "news_date": "2021-06-19 10:43:12",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31-03-2021",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th June, 2021 (i.e. today), inter-alia, considered and approved the following items: <BR> 1. Considered and approved the Audited Financial Results for the quarter and financial year ended March 31, 2021, along with the audit report of the statutory auditor.<BR> 2. Noted the resignation of Ms. Madhumita Ganguli (DIN : 00676830) as 'Non-Executive Non-Independent Director'   from the Board of Directors of the Company.<BR> 3. Appointed Ms. Madhumita Ganguli (DIN :  00676830) as Independent Director of the Company, for a period of 5 consecutive years effective from 9th June, 2021 to  8th June, 2026, subject to the approval of the shareholders of the Company.<BR> Further, we wish to inform you that due to the impact of COVID-19 and uncertainty of growth in business, dividend on shares for the year 2020-21, has not been recommended by the Board.<BR>",
            "news_id": "eed9f2e1-23f9-40ff-a735-ce7105e2c99d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06c49759-b6d8-494f-8b5e-6f9d04359d49.pdf",
            "news_date": "2021-06-09 18:07:29",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th June, 2021 (i.e. today), inter-alia, considered and approved the following items: <BR> 1. Considered and approved the Audited Financial Results for the quarter and financial year ended March 31, 2021, along with the audit report of the statutory auditor.<BR> 2. Noted the resignation of Ms. Madhumita Ganguli (DIN : 00676830) as 'Non-Executive Non-Independent Director'   from the Board of Directors of the Company.<BR> 3. Appointed Ms. Madhumita Ganguli (DIN :  00676830) as Independent Director of the Company, for a period of 5 consecutive years effective from 9th June, 2021 to  8th June, 2026, subject to the approval of the shareholders of the Company.<BR> Further, we wish to inform you that due to the impact of COVID-19 and uncertainty of growth in business, dividend on shares for the year 2020-21, has not been recommended by the Board.<BR>",
            "news_id": "81a3a54f-3548-4415-b887-06de3d660558",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b87bda7-0b36-41bc-9e95-3ab1e2f193f8.pdf",
            "news_date": "2021-06-09 18:05:17",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}